2025-03-10 00:39:33
Latest Post
MAN Industries India Ltd inaugurates Advanced Spiral Mill and Coating Facility with 50,000 TPA Capacity in Pithampur
Manoj Vaibhav Gems 'N' Jewellers Ltd opens new Jewellery Store at Palasa, Andhra Pradesh
Baazar Style Retail Limited opens new store at Sipara, Patna
Truck Rentals remain lacklustre in February amid tepid Infrastructure Demand: Shriram Mobility Bulletin
India levies anti-dumping duty on imports of Trichloro Isocyanuric Acid from China PR and Japan
Stock Report
Sun Pharmaceutical Industries Ltd consolidated Q2 FY2023-24 PAT higher at Rs. 2375.51 crores
Posted On : 2023-11-01 19:57:49( TIMEZONE : IST )
Sun Pharmaceutical Industries Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023 as compared to Rs. 12145.28 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 2375.51 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 2022.54 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 9.9 for the period ended September 30, 2023 as compared to Rs. 8.4 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹12486.02 crs | ₹12145.28 crs |  2.81% |
| Net Profit | ₹2375.51 crs | ₹2022.54 crs | 17.45% |
| EPS | ₹9.9 | ₹8.4 | 17.86% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs.12486.02 crores during the period ended September 30, 2023 as compared to Rs.11037.50 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.2375.51 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.2262.22 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.9.9 for the period ended September 30, 2023 as compared to Rs.9.4 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹12486.02 crs | ₹11037.50 crs | 13.12% |
| Net Profit | ₹2375.51 crs | ₹2262.22 crs | 5.01% |
| EPS | ₹9.9 | ₹9.4 | 5.32% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.24631.30 crores during the 6 Months period ended September 30, 2023 as compared to Rs.21801.40 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.4398.05 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.4323.10 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.18.3 for the 6 Months period ended September 30, 2023 as compared to Rs.18 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹24631.30 crs | ₹21801.40 crs | 12.98% |
| Net Profit | ₹4398.05 crs | ₹4323.10 crs | 1.73% |
| EPS | ₹18.3 | ₹18 | 1.67% |
Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1116.15 as compared to the previous close of Rs. 1088.70. The total number of shares traded during the day was 208546 in over 5764 trades.
The stock hit an intraday high of Rs. 1120.30 and intraday low of 1082.80. The net turnover during the day was Rs. 231362988.00.
